TC Pharmaceuticals (Jiangsu) Co., Ltd., formerly known as Yungshin Pharmaceutical Industry (Kunshan) Co., Ltd., was a subsidiary of Yungshin Pharmaceutical Group. Founded in December 1994, it was separated from Yungshin Pharmaceutical Group and became an independent company in June 2022. It manufactures and sells tablets, capsules, ointments, injections, and gels. TC Pharmaceuticals (Jiangsu) Co., Ltd. is located in Lujia, Kunshan and covers an area of 94,055 square meters. The manufacturing facility of the company is built in accordance with the current GMP standards. Critical manufacturing equipment, analysis and testing instruments are imported from distinguished manufacturers all over the world, which are fully in line with international standards. In addition, the continuous training and re-education of personnel ensure that the drug manufacturing process aligns with GMP standards.
TC Pharmaceuticals (Jiangsu) Co., Ltd. was GMP certified by the State Food and Drug Administration on May 15, 1999, and passed FDA inspection in 2009, becoming the second pharmaceutical manufacturer in China that can directly export its products to the United States.
TC Pharmaceuticals adopted the SAP ERP Management System in 2009, and the injection production line passed the GMP inspection of SFDA in the same year. At present, the main product dosage forms include tablets, capsules, ointments, etc. The annual production capacity can reach 350 million tablets, 520 million capsules and 6.25 million tubes of ointments. The new injection workshop has an annual production capacity of 30 million ampoules.
Continuous innovation is the only guarantee for the sustainable operation of a company. TC Pharmaceuticals, which has consistently committed to the research and development of new products, has also invested a significant amount of manpower and funds into the research and development work in Kunshan, China. It is expected to serve the Chinese people with advanced products. TC Pharmaceuticals has been recognized by the Jiangsu Provincial Bureau of Science and Technology, the Kunshan Municipal Bureau of Science and Technology, and the Kunshan Municipal Government. It was recognized as both a Jiangsu Provincial Foreign-funded R&D Institutions and a Kunshan Foreign-funded R&D Institutions. In 2011, it was also awarded the "Jiangsu Provincial High-tech Enterprise" certification.
The company will continue to improve the living standard for the Chinese people by providing quality pharmaceutical products and elevating health standards.